Skip to main content
Screener/Healthcare/Biotechnology

KYTX Kyverna Therapeutics, Inc.

NASDAQ
$7.08-0.44 (-5.86%)
$5.27
$13.67
$7.02
$7.54
EPS (TTM)$-3.28
P/E Ratio-2.54
Dividend Yield
Market Cap$433.5M
Volume260K
Prev Close$7.51
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$39.7M$-0.66
Q4 '25$0-$37.8M$-0.80
Q3 '25$0-$36.8M$-0.85
Q2 '25$0-$42.1M$-0.97
Q1 '25$0-$44.6M$-1.03
Q4 '24$0-$37.5M$-0.87
Q3 '24$0-$34.5M$-0.80
Q2 '24$0-$28.8M$-0.67
Get Your Daily Market Recap